The UK Pharmaceutical Industry Braces for Brexit

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

ABOVE: © ISTOCK.COM, STUART RITCHIE

Next week, leaders of the 28 countries making up the European Union will meet in Brussels to try to hammer out the terms of Britain’s exit from the coalition, or Brexit. It will be one of the last chances to do so before the country departs on March 29, 2019.

Britain stunned the world in June 2016 when a slight but significant majority of voters elected to leave the EU. The decision has left many businesses, including pharmaceutical firms, rushing to prepare for the changes that Brexit will bring. “A vote to leave is the gamble of the century,” David Cameron, then British prime minister, wrote months ahead of the referendum. “And it would be our children’s futures on the table if we were to roll the dice.”

Belonging to the EU means being part of the single market, which allows people, goods, services, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Diana Kwon

    Diana is a freelance science journalist who covers the life sciences, health, and academic life.

Published In

December 2018

Invisible Borders

An emerging appreciation for membraneless organelles and the liquid dynamics that shape them

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio